This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Japan Tobacco Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Atushi Sakai - Innovator in Pharmaceutical Compounds
Introduction
Atushi Sakai is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on cyclopropane compounds. His research focuses on developing therapeutic agents for various medical conditions, including osteoarthritis and rheumatoid arthritis.
Latest Patents
Atushi Sakai holds a patent for "Cyclopropane compounds and pharmaceutical use thereof." This invention provides a compound with aggrecanase inhibitory activity and MMP-13 inhibitory activity, which is useful as a therapeutic agent for osteoarthritis and rheumatoid arthritis. The patent details a cyclopropane compound of specific formulas, highlighting its potential in medical applications.
Career Highlights
Sakai is currently associated with Japan Tobacco Inc., where he continues to advance his research in pharmaceutical innovations. His work has garnered attention for its potential impact on treating debilitating conditions that affect many individuals worldwide.
Collaborations
Atushi Sakai collaborates with esteemed colleagues, including Takashi Inaba and Julia Haas. Their combined expertise contributes to the development of groundbreaking pharmaceutical solutions.
Conclusion
Atushi Sakai's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare. His work exemplifies the importance of research and innovation in developing effective treatments for chronic conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile